PEPTIDE DRUG ASSAYS
Peptides are recognized for being highly selective and efficacious and, at the same time, relatively safe and well tolerated. Consequently, there is an increased interest in peptides in pharmaceutical research and development (R&D), and approximately 140 peptide therapeutics are currently being evaluated in clinical trials. Given that the low-hanging fruits in the form of obvious peptide targets have already been picked, it has now become necessary to explore new routes beyond traditional peptide design. Examples of such approaches are multifunctional and cell penetrating peptides, as well as peptide drug conjugates.
Furthermore, peptide therapeutics are typically associated with lower production complexity compared with protein-based biopharmaceuticals and, therefore, the production costs are also lower, generally approaching those of small molecules. Thus, in several ways, peptides are in the sweet spot between small molecules and biopharmaceuticals.
KRISHGEN offers the advantage and experience of making available a wide range of immunoassays in the ELISA format for your clinical studies.
Davalintide ELISADegarelix (FIRMAGON*) ELISADeslorelin (OVUPLANT*) ELISA
*Note: All trademarks and brands are properties of their respective owners.
Showing 1–24 of 33 results